diaMentis

Founded in Quebec City in 2015, diaMentis is the first company to develop a software as medical device (SaMD) that analyses information from a simple examination of the eye (electroretinography). Mission: Develop, valorise, patent and market (directly or indirectly) a diagnostic tool for better management of patients with mental disorders in a personalised healthcare environment. diaMentis value proposition: A non-invasive, not expensive and easy to implement test A reliable method of analysis Fast results via a centralized service diaMentis technology will lead to: More accurate and faster diagnosis Appropriate choice of treatments and psychotherapy Better acceptance of the disease by...

Santé mentale,biotechnologie,psychiatrie,innovation,software as a medical device,électrorétinographie,médecine personnalisée,schizophrénie,bipolarité,dépression majeure,anxiété,mental health,biotechnology,psychiatry,electroretinography,personalized medicine,schizophrenia,bipolarity,major depression,and anxiety

Diamentis operates in the Biotechnology industry.

Diamentis's revenue is 11m - 100m

Diamentis has 11 - 50 employees.